Compounds > u 74500a
Page last updated: 2024-09-02

u 74500a and Dyskinesia, Drug-Induced

u 74500a has been researched along with Dyskinesia, Drug-Induced in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishnoi, M; Boparai, RK1
Bishnoi, M; Chopra, K; Kulkarni, SK1

Other Studies

2 other study(ies) available for u 74500a and Dyskinesia, Drug-Induced

ArticleYear
An animal model to study the molecular basis of tardive dyskinesia.
    Methods in molecular biology (Clifton, N.J.), 2012, Volume: 829

    Topics: Animals; Antipsychotic Agents; Apoptosis; Behavior, Animal; Caspase 3; Clozapine; Disease Models, Animal; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Movement Disorders; Pregnatrienes; Rats; Rats, Wistar

2012
U-74500A (lazaroid), a 21-aminosteroid attenuates neuroleptic-induced orofacial dyskinesia.
    Methods and findings in experimental and clinical pharmacology, 2007, Volume: 29, Issue:9

    Topics: Animals; Antioxidants; Antipsychotic Agents; Chlorpromazine; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Haloperidol; Male; Movement Disorders; Pregnatrienes; Rats; Rats, Wistar

2007